ACXP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Acurx Pharmaceuticals Inc (ACXP) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock shows bearish technical indicators, weak financial performance, and no significant positive catalysts. The lack of trading trends, news, or influential trading activity further supports a cautious approach.
The stock exhibits bearish moving averages (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. The RSI is neutral at 25.666, and the MACD histogram is slightly positive at 0.00827, suggesting minimal momentum. Key support lies at 1.435, with resistance at 1.629. The price is currently near support levels, but no clear reversal signals are present.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data. The AI Stock Picker and SwingMax signals are also absent.
The stock has declined by -4.61% in the last session. Financial performance is weak, with net income and EPS showing significant YoY declines (-29.37% and -64.35%, respectively). Revenue remains at 0, and gross margin is stagnant. The overall market sentiment is slightly negative, with the S&P 500 down -0.56%.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$1,992,790 (-29.37% YoY), and EPS fell to -1.23 (-64.35% YoY). Gross margin showed no improvement. The company is struggling financially, which raises concerns about its long-term viability.
No analyst rating or price target data is available for ACXP.
